Accelerating delivery of radiopharmaceutical trials
Radiopharmaceutical trials are gaining traction across oncology and other therapeutic areas—but challenges remain in delivery, access, and scalability. In this expert-led webinar, leaders in clinical research, regulatory strategy, operational execution, and patient advocacy explore how to de-risk and accelerate these programs through integrated planning and patient-focused design.
Hear directly from experts who have helped sponsors navigate the complexities of radiopharmaceutical development—from aligning nuclear medicine and oncology teams to designing inclusive trials and enabling access beyond academic hubs. Also featured is an oncology patient who participated in a radiopharmaceutical clinical trial, and he shares his journey and perspective on what drives patient engagement.
Related Insights
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Article
Decentralized trial tools and technologies are here to stay: A regulatory perspective
Jul 23, 2021
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Related Insights
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Navigating the challenges of large, international Phase III breast cancer trials
Jul 29, 2025
Podcast
Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Article
Decentralized trial tools and technologies are here to stay: A regulatory perspective
Jul 23, 2021
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Operational strategies for faster, more efficient pivotal NSCLC trials
Sep 17, 2025
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024